A comprehensive view of epidemic / pandemic. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.
GlobalData: Success of mRNA vaccine technology during Covid-19 pandemic could lead to using platform to reduce preventable illness across multiple disease areas; about 507 preventive vaccines in late-stage development, with 88 using mRNA technology
Published:
April 24, 2024
by Indo-Asian News Service
|
Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published:
April 24, 2024
by CE Noticias Financieras (Latin America)
|
Roche reports group sales increase by 2% year-over-year due to the success of newer medicines and diagnostics, independent of COVID-19 products; the surge was offset by the strengthening of the Swiss franc and a decline in COVID-19 test demand
Published:
April 24, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
Moderna brings Pfizer/BioNTech to court in London claiming patent breach over COVID-19 vaccine technology; Pfizer and BioNTech deny the allegations and call for two Moderna patents to be declared invalid
Published:
April 23, 2024
by AFP World News
|
Study finds 1 in 4 antibiotic prescriptions in America are unnecessary, exacerbating survival chances for drug-resistant bacteria; the trend worsened during the COVID-19 pandemic, despite initial declines: University of Michigan, others
Published:
April 22, 2024
by University of Michigan Institute for Healthcare Policy & Innovation
|
Ask us about our Sustainability & Social Responsibility market view